NS38375/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2001	2
2002	5
2003	3
2004	1
2005	3
2007	1
2008	2
2009	1
2024	0

1

Multiple system atrophy: a primary oligodendrogliopathy.

Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG. Wenning GK, et al. Ann Neurol. 2008 Sep;64(3):239-46. doi: 10.1002/ana.21465. Ann Neurol. 2008. PMID: 18825660 Review.

2

Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.

Volles MJ, Lansbury PT Jr. Volles MJ, et al. Biochemistry. 2003 Jul 8;42(26):7871-8. doi: 10.1021/bi030086j. Biochemistry. 2003. PMID: 12834338 Review.

3

Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease.

Rochet JC, Outeiro TF, Conway KA, Ding TT, Volles MJ, Lashuel HA, Bieganski RM, Lindquist SL, Lansbury PT. Rochet JC, et al. J Mol Neurosci. 2004;23(1-2):23-34. doi: 10.1385/jmn:23:1-2:023. J Mol Neurosci. 2004. PMID: 15126689 Review.

4

Dopamine covalently modifies and functionally inactivates parkin.

LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ. LaVoie MJ, et al. Nat Med. 2005 Nov;11(11):1214-21. doi: 10.1038/nm1314. Epub 2005 Oct 16. Nat Med. 2005. PMID: 16227987

5

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr. Conway KA, et al. Science. 2001 Nov 9;294(5545):1346-9. doi: 10.1126/science.1063522. Science. 2001. PMID: 11701929

6

The effects of oxidative stress on parkin and other E3 ligases.

LaVoie MJ, Cortese GP, Ostaszewski BL, Schlossmacher MG. LaVoie MJ, et al. J Neurochem. 2007 Dec;103(6):2354-68. doi: 10.1111/j.1471-4159.2007.04911.x. Epub 2007 Sep 19. J Neurochem. 2007. PMID: 17883392 Free article.

7

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.

Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, Lansbury PT Jr. Lashuel HA, et al. J Mol Biol. 2002 Oct 4;322(5):1089-102. doi: 10.1016/s0022-2836(02)00735-0. J Mol Biol. 2002. PMID: 12367530

8

Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo.

Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, Kolodziej P, Boston H, Saftig P, Woulfe J, Feany MB, Myllykangas L, Schlossmacher MG, Tyynelä J. Cullen V, et al. Mol Brain. 2009 Feb 9;2:5. doi: 10.1186/1756-6606-2-5. Mol Brain. 2009. PMID: 19203374 Free PMC article.

9

Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.

Schlossmacher MG, Frosch MP, Gai WP, Medina M, Sharma N, Forno L, Ochiishi T, Shimura H, Sharon R, Hattori N, Langston JW, Mizuno Y, Hyman BT, Selkoe DJ, Kosik KS. Schlossmacher MG, et al. Am J Pathol. 2002 May;160(5):1655-67. doi: 10.1016/S0002-9440(10)61113-3. Am J Pathol. 2002. PMID: 12000718 Free PMC article.

10

Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line.

Liu Y, Lashuel HA, Choi S, Xing X, Case A, Ni J, Yeh LA, Cuny GD, Stein RL, Lansbury PT Jr. Liu Y, et al. Chem Biol. 2003 Sep;10(9):837-46. doi: 10.1016/j.chembiol.2003.08.010. Chem Biol. 2003. PMID: 14522054

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year